We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Trade Group Blasts "Authorized Generic" Deals

Law360 (March 3, 2004, 12:00 AM EST) -- Generic drug makers denounced the practice of "authorized generics," arguing that such agreements devalue the 180-day exclusivity provisions of the Hatch-Waxman Act.

"We urge the U.S. Food and Drug Administration to maintain the spirit and intent of the 180-day exclusivity period which was strengthened in last year's Medicare reform bill," said Kathleen Jaeger, President and Chief Executive Officer of the Generic Pharmaceutical Association (GPhA), an industry trade group.

Under "authorized generics" agreements, a brand drugmaker licenses its product to a generic firm, which launches the authorized...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.